STAHIST AD

Manufacturer: Magna Pharmaceuticals, Inc.
Effective date: 2025-10-03
Label type: HUMAN OTC DRUG LABEL
Version: 8
Source: full-release
Hydrated at: 2026-06-01 01:15:51

Label at a glance#

ProductSTAHIST AD

Active ingredientCHLORCYCLIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE

Label structure9 sections

Indications and uses

temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies: runny nose sneezing itching of the nose or throat itchy, watery eyes nasal congestion reduces swelling of nasal passages

Dosage and administration

Do not exceed recommended dosage. Adults and children 12 years of age and over: 1 tablet by mouth every 6-8 hours, not to exceed 3 tablets in 24 hours, or as directed by a doctor Children 6 to under 12 years of age: ½ tablet by mouth every 6-8 hours, not to exceed 1½ tablets in 24 hours, or as directed by a doctor Children under 6 years of age Consult a doctor

Contacts and useful links#

PhoneLabel contact1-888-206-5525

Websitewww.magnaweb.com

www.magnaweb.com

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

OTC - PURPOSE SECTION

Active Ingredients (in each immediate-release tablet)	Purpose
Chlorcyclizine HCl 25 mg	Antihistamine
Pseudoephedrine HCl 60 mg	Nasal Decongestant

Uses

INDICATIONS & USAGE SECTION

temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies:

runny nose
sneezing
itching of the nose or throat
itchy, watery eyes
nasal congestion
reduces swelling of nasal passages

Warnings

WARNINGS SECTION

Do not exceed recommended dosage.

Do not use this product

OTC - DO NOT USE SECTION

If you are taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for two weeks after stopping the MAOI drug. If you do not know if your prescription drug contains MAOI, ask a doctor or pharmacist before taking this product.

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

a breathing problem such as emphysema or chronic bronchitis
glaucoma
heart disease
high blood pressure
thyroid disease
diabetes melitus
difficulty in urination due to enlargement of the prostate gland

OTC - ASK DOCTOR/PHARMACIST SECTION

Ask a doctor before use if you are taking sedatives or tranquilizers

When using this product

OTC - WHEN USING SECTION

excitability may occur, especially in children
may cause drowsiness
alcohol, sedatives and tranquilizers may increase drowsiness effect
avoid alcoholic beverages
use caution when driving a motor vehicle or operating machinery

Stop use and ask a doctor if

OTC - STOP USE SECTION

nervousness, dizziness or sleeplessness occur
symptoms do not improve within 7 days or are accompanied by fever
new symptoms occur

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding,ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

In case of accidental overdose, seek professional help or contact a Poison Control Center immediately.

Directions

DOSAGE & ADMINISTRATION SECTION

Do not exceed recommended dosage.

Adults and children 12 years of age and over:	1 tablet by mouth every 6-8 hours, not to exceed 3 tablets in 24 hours, or as directed by a doctor
Children 6 to under 12 years of age:	½ tablet by mouth every 6-8 hours, not to exceed 1½ tablets in 24 hours, or as directed by a doctor
Children under 6 years of age	Consult a doctor

Inactive ingredients

INACTIVE INGREDIENT SECTION

Magnesium Stearate, Microcrystalline Cellulose, Sodium Starch Glycolate

Questions or Comments?

OTC - QUESTIONS SECTION

Call 1-888-206-5525 • www.magnaweb.com

SPL UNCLASSIFIED SECTION

Rev. 10/11

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Stahist AD Principal Display Panel

Add image transcription here...

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
1235861	chlorcyclizine HCl 25 MG / pseudoephedrine HCl 60 MG Oral Tablet	PSN	8
1236716	Stahist AD 25 MG / 60 MG Oral Tablet	PSN	8
1236716	chlorcyclizine hydrochloride 25 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet [Stahist AD]	SBD	8
1235861	chlorcyclizine hydrochloride 25 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet	SCD	8
1236716	Stahist AD (chlorcyclizine hydrochloride 25 MG / pseudoephedrine hydrochloride 60 MG) Oral Tablet	SY	8

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
PSEUDOEPHEDRINE Pharmacologic Class Indexing	2	Indexing - Pharmacologic Class	20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
ba088a92-ab5e-b2d4-e908-f5ea691b7587	Product name	7	20210201
0fdb98e2-b951-a1ce-5715-2b187ba500ef	Product name	4	20170718
e974e22d-8688-7d92-1e87-40c1079e170c	Product name	3	20151125
e8718272-64cb-4436-969b-176c3067c8f4	Product name	1	20150609
30c51294-7ae9-8007-7de6-58222684a0be	Product name	1	20140508
4f26f669-fc6c-40ef-9e26-1c7b2390ee66	Product name	1	20140508
70a83adc-6047-bbea-5a08-dfd304aa47d2	Product name	1	20140508
858ce051-9941-aafc-8c7c-44a8e0227463	Product name	1	20140508
b893258d-0942-3d8a-3411-056ea0788ff5	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
58407-625-01	2023-11-06	C162847	48780-1	ba0f9c33-322b-a910-e053-dadaa90a0b85	Stahist AD
58407-625-06	2023-11-06	C162847	48780-1	ba0f9c33-322b-a910-e053-dadaa90a0b85	Stahist AD
58407-625-30	2023-11-06	C162847	48780-1	ba0f9c33-322b-a910-e053-dadaa90a0b85	Stahist AD
58407-625-01	2023-07-28	C162847	48780-1	ba0f9c33-322b-a910-e053-dadaa90a0b85	Stahist AD
58407-625-06	2023-07-28	C162847	48780-1	ba0f9c33-322b-a910-e053-dadaa90a0b85	Stahist AD
58407-625-30	2023-07-28	C162847	48780-1	ba0f9c33-322b-a910-e053-dadaa90a0b85	Stahist AD
58407-625-01	2022-08-17	C162847	48780-1	ba0f9c33-322b-a910-e053-dadaa90a0b85	Stahist AD
58407-625-06	2022-08-17	C162847	48780-1	ba0f9c33-322b-a910-e053-dadaa90a0b85	Stahist AD
58407-625-30	2022-08-17	C162847	48780-1	ba0f9c33-322b-a910-e053-dadaa90a0b85	Stahist AD
58407-625-01	2021-01-29	C162847	48780-1	ba0f9c33-322b-a910-e053-dadaa90a0b85	Stahist AD
58407-625-06	2021-01-29	C162847	48780-1	ba0f9c33-322b-a910-e053-dadaa90a0b85	Stahist AD
58407-625-30	2021-01-29	C162847	48780-1	ba0f9c33-322b-a910-e053-dadaa90a0b85	Stahist AD

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
58407-625-01	STAHIST AD	1 in 1 BLISTER PACK	TABLET	1	8
58407-625-06	STAHIST AD	6 in 1 BOX	TABLET	6	8
58407-625-30	STAHIST AD	30 in 1 BOTTLE	TABLET	30	8
58407-625-30	STAHIST AD	1 in 1 BOX	TABLET	1	8

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
58407-625-30	EA - Each	58407-625	1514b49e-4e09-4f4f-bcde-62b65472665c	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
CHLORCYCLIZINE HYDROCHLORIDE	ACTIVE INGREDIENT	NPB7A7874U	1
PSEUDOEPHEDRINE HYDROCHLORIDE	ACTIVE INGREDIENT	6V9V2RYJ8N	1
CHLORCYCLIZINE	ACTIVE MOIETY	M26C4IP44P	1
PSEUDOEPHEDRINE	ACTIVE MOIETY	7CUC9DDI9F	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	1
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

STAHIST AD
CHLORCYCLIZINE HYDROCHLORIDE and PSEUDOEPHEDRINE HYDROCHLORIDE
MICROCRYSTALLINE CELLULOSE
MAGNESIUM STEARATE
SODIUM STARCH GLYCOLATE TYPE A POTATO
CHLORCYCLIZINE HYDROCHLORIDE
CHLORCYCLIZINE
PSEUDOEPHEDRINE HYDROCHLORIDE
PSEUDOEPHEDRINE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
58407-625	58407-625-30, 58407-625-01, 58407-625-06

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
MICROCRYSTALLINE CELLULOSE	OP1R32D61U	IACT
MAGNESIUM STEARATE	70097M6I30	IACT
SODIUM STARCH GLYCOLATE TYPE A POTATO	5856J3G2A2	IACT
CHLORCYCLIZINE HYDROCHLORIDE	NPB7A7874U	ACTIB
PSEUDOEPHEDRINE HYDROCHLORIDE	6V9V2RYJ8N	ACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 8 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Maximum daily exposure	Match
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET / ORAL	6184 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET / ORAL	980 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET / ORAL	980 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET / ORAL	980 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET / ORAL	6184 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET / ORAL	980 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET / ORAL	6184 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET / ORAL	6184 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
STAHIST AD	CHLORCYCLIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE	Magna Pharmaceuticals, Inc.	ccedbc38-2479-4c35-9f86-a9f29bcfab3f	2025-10-03	Warnings	Exact identifier ndc (package): 58407-625-30 ndc (package): 58407-625-01 ndc (package): 58407-625-06 ndc (product): 58407-625 ndc11 (package): 58407062506 ndc11 (package): 58407062501 ndc11 (package): 58407062530 spl id: 4041d3f9-d1cb-0931-e063-6394a90a82de spl set id: ccedbc38-2479-4c35-9f86-a9f29bcfab3f

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.